000 01428 a2200409 4500
005 20250511201147.0
264 0 _c19901115
008 199011s 0 0 eng d
022 _a0921-299X
024 7 _a10.1007/BF02173519
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRosenzweig, I B
245 0 0 _aEffects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein.
_h[electronic resource]
260 _bBiotherapy (Dordrecht, Netherlands)
_c1990
300 _a193-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aApolipoprotein A-I
650 0 4 _aApolipoproteins A
_xblood
650 0 4 _aC-Reactive Protein
_xmetabolism
650 0 4 _aCholesterol, HDL
_xblood
650 0 4 _aCholesterol, LDL
_xblood
650 0 4 _aHumans
650 0 4 _aInterferons
_xpharmacology
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aLipids
_xblood
650 0 4 _aLipoproteins
_xblood
650 0 4 _aTriglycerides
_xblood
700 1 _aWiebe, D A
700 1 _aHank, J A
700 1 _aAlbers, J J
700 1 _aAdolphson, J L
700 1 _aBorden, E
700 1 _aShrago, E S
700 1 _aSondel, P M
773 0 _tBiotherapy (Dordrecht, Netherlands)
_gvol. 2
_gno. 3
_gp. 193-8
856 4 0 _uhttps://doi.org/10.1007/BF02173519
_zAvailable from publisher's website
999 _c1704822
_d1704822